PeptidePicker
RecoveryResearch

KPV

Also known as: Lysine-Proline-Valine · Alpha-MSH Fragment

A master anti-inflammatory tripeptide derived from alpha-MSH. Obliterates systemic inflammation at the genetic level without immunosuppression, making it a staple for IBD and gut health.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~30 minutes

Typical Dose

200–500 mcg

Administration

Subcutaneous injection, oral, or topical

Mechanism of Action

Enters cells and inhibits NF-kB inflammatory signaling at the nuclear level, reducing TNF-alpha, IL-6, and other pro-inflammatory cytokines.

Key Research Areas

anti-inflammatorygut healthIBDskinautoimmune

Frequently Asked Questions

What is KPV?
A master anti-inflammatory tripeptide derived from alpha-MSH. Obliterates systemic inflammation at the genetic level without immunosuppression, making it a staple for IBD and gut health.
How does KPV work?
Enters cells and inhibits NF-kB inflammatory signaling at the nuclear level, reducing TNF-alpha, IL-6, and other pro-inflammatory cytokines.
What is the recommended dosage for KPV?
The typical research dosage is 200–500 mcg, administered via Subcutaneous injection, oral, or topical. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of KPV?
The half-life of KPV is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is KPV FDA approved?
KPV is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about KPV is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Recovery